Prescribing quality in medical specialists in Isfahan, Iran

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 1, 2013, Pages 235-241

  Sadeghian, Gholam Hossein ^a   Safaeian, Leila ^a   Mahdanian, Ali Reza ^a   Salami, Solmaz ^a   Kebriaee Zadeh, Javad ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug prescription; Drug utilization; Health care; Prescribing practice; Quality indicators

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DRUG USE; DRUG UTILIZATION; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HUMAN; INAPPROPRIATE PRESCRIBING; IRAN; MEDICAL SPECIALIST; PRESCRIPTION;

EID: 84874718187     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akoria OA and Isah AO. Prescription writing in public and private hospitals in Benin City, Nigeria. The effects of an educational intervention. Can. J. Clin. Pharmacol. (2008) 15: 295-305.
2. Holloway K. Who contributes to misuse of antimicrobials? Essential Drugs Monitor. (2000) 9: 9.
3. Shivhare1 SC, Kunjwani HK, Manikrao AM and Bondre AV. Drugs hazards and rational use of drugs: a review. J. Chem. Pharm. Res. (2010) 2: 106-112.
4. Aronson JK. Medication errors: what they are, how they happen, and how to avoid them. QJM. (2009) 102: 513-521.
5. Garjani A, Salimnejad M and Maleki N. The effect of interactive group discussion among physicians to promote rational use of drugs. J. Med. Edu. (2006) 8: 73-81.
6. De Vries TPGM, Henning RH, Hogerzeil HV and Fresle DA. Guide to good prescribing. WHO/Geneva: World Health Organization Press 1994.
7. Hogerzeil HV. Promoting rational prescribing: an international perspective. Br. J. Clin. Pharmac. (1995) 39: 1-6.
8. How to investigate drug use in health facilities (selected drug use indicators). WHO/DAP/93.1 Geneva: World Health Organization Press 1993.
9. Donohoe MT. Comparing generalist and specialty care: discrepancies, defciencies, and excesses. Arch. Intern. Med. (1998) 158: 1596-1608.
10. Bosu WK and Ofori-Adjei D. An audit of prescribing practices in health care facilities of the Wassa west district of Ghana. West. Afr. J. Med. (2000) 19: 298-303.
11. AHFS Drug information essentials, a resource for health care professionals, American Society of Health-System Pharmacists, Bethesda, USA 2009.
12. Cheraghali AM. Iran Pharmaceutical Market. Iran. J. Pharm. Res (2006) 1: 1-7.
13. Odunsanya OO. Drug use indicators at secondary health care facility in Lagos, Nigeria. J. Commun. Med. Health Care (2004) 16: 21-24.
14. Hogerzeil HV, Walker GJ, Sallami AO and Fernando G. Impact of an essential drugs programme on availability and rational use of drugs. Lancet (1989) 1: 141-142.
15. Aronson JK, Henderson G, Webb DJ and Rawlins MD. A prescription for better prescribing. BMJ. (2006) 333: 459-460.
16. Kravitz R, Greenfeld S, Rogers W, Manning WG, Zubkoff M, Nelson EC, Tarlov AR and Ware GE. Differences in the mix of patients among medical specialties and systems of care: results from the medical outcomes study. JAMA. (1992) 267: 1617-1623.
17. Vallano A, Montane E, Arnau JM, Vidal X, C. Pallare, Coll M, Coll M and Laporte JR. Medical speciality and pattern of medicines prescription. Eur. J. Clin. Pharmacol. (2004) 60: 725-730.
18. Hamadeh GN, Dickerson LM, Saab BR and Major SC. Common prescriptions in ambulatory care in Lebanon. Ann. Pharmacother. (2001) 35: 636-640.
19. Otoom S, Batieha A, Hadidi H, Hasan M and Al-Saudi K. Evaluation of drug use in Jordan using prescribing indicators. East Mediterr. Health J. (2002) 8: 537-543.
20. Roumie CR, Halasa NB, Grijalva CG, Edwards KM, Zhu Y, Dittus RS and Griffn MR. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J. Gen. Intern. Med. (2005) 20: 697-702.
21. Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Stichele RHV, Verheij TJM, Monnet DL, Little P and Goossens H. European surveillance of antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual. Saf. Health Care (2007) 16: 440-445.
22. Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafe KK, Mabadeje AFB and Massele YA. Field tests for rational drug use in twelve developing countries. Lancet (1993) 342: 1408-1410.
23. Janjua NZ, Akhtar S and Hutin YJ. Injection use in two districts of Pakistan: implications for disease prevention. Int. J. Qual. Health Care (2005) 17: 401-408.
24. Carpi J. Generalists trail allergists in giving inhaled steroids. Internal Medical News (1995) 15: 1.
25. Imam AP and Halpern GM. Uses, adverse effects of abuse of corticosteroids. Part I. Allergol. Immunopathol. (Madr) (1994) 22: 250-260.
26. Turner BJ and Christine Laine. Differences between generalists and specialists knowledge, realism, or primum non nocere? J. Gen. Intern. Med. (2001) 16: 422-424.
27. Ahmadizar F, Soleymani F and Abdollahi M. Study of Drug-Drug Interactions in Prescriptions of General Practitioners and Specialists in Iran 2007-2009. Iranian J. Pharm. Res. (2011) 10: 921-931.
28. Nair HS, Manchanda P and Bhatia T. Asymmetric social interactions in physician prescription behavior: the role of opinion leaders. J. Marketing Res. (2010) 47: 883-895.
29. Soleymani F, Valadkhani M and Dinarvand R. Challenges and achievements of promoting rational use of drugs in Iran. Iranian J. Publ. Health (2009) 38: 166-168.